We also identified a novel role for FAK in regulating the expression of ICOS, primarily on CD8eff T-cells, and showed that blocking ICOS ligand could impair the anti-tumor efficacy of both FAK/anti-OX40 and FAK/anti-4-1BB combinations. The gene discussed is PTK2; the disease is neoplasm.